Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice

Neuroscience

Volumn 163, Issue 1, 2009, Pages 55-72

  Sanchez Ramos, J ^a,b,d   Song, S ^a,b   Sava, V ^a,b   Catlow, B ^a,b   Lin, X ^d   Mori, T ^c   Cao, C ^d   Arendash, G W ^e,f  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d Research Institute   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

amyloid; bone marrow; hippocampus; microglia; neurogenesis; synaptophysin

Indexed keywords

AMYLOID BETA PROTEIN; CALRETININ; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SYNAPTOPHYSIN;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENTATE GYRUS; ENTORHINAL CORTEX; HIPPOCAMPUS; IMMUNOMODULATION; LEARNING; MENTAL PERFORMANCE; MICROGLIA; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SHORT TERM MEMORY; SPATIAL MEMORY; WORKING MEMORY;

ALZHEIMER DISEASE; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL MOVEMENT; COGNITION DISORDERS; CYTOKINES; DENTATE GYRUS; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENTORHINAL CORTEX; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; MICROGLIA; NEUROGENESIS; NEUROPROTECTIVE AGENTS; SENILE PLAQUES; SYNAPTOPHYSIN;

EID: 68349127365     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.05.071     Document Type: Article

References (66)

1. Alvarez-Dorado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., and Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
2. Arendash G.W., Garcia M.F., Costa D.A., Cracchiolo J.R., Wefes I.M., and Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport 15 (2004) 1751-1754
3. Arendash G.W., Gordon M.N., Diamond D.M., Austin L.A., Hatcher J.M., Jantzen P., DiCarlo G., Wilcock D., and Morgan D. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol 20 (2001) 737-744
4. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., and Diamond D.M. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891 (2001) 42-53
5. Arendash G.W., Schleif W., Rezai-Zadeh K., Jackson E.K., Zacharia L.C., Cracchiolo J.R., Shippy D., and Tan J. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142 (2006) 941-952
6. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., and Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6 (2000) 916-919
7. Bolmont T., Haiss F., Eicke D., Radde R., Mathis C.A., Klunk W.E., Kohsaka S., Jucker M., and Calhoun M.E. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. Neurobiol Dis 28 (2008) 4283-4292
8. Boneberg E.M., Hareng L., Gantner F., Wendel A., and Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 95 (2000) 270-276
9. Buttini M., Masliah E., Barbour R., Grajeda H., Motter R., Johnson-Wood K., Khan K., Seubert P., Freedman S., Schenk D., and Games D. Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci 25 (2005) 9096-9101
10. h2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS. Neurobiol Dis 34 (2009) 63-70
11. Cardona A.E., Huang D., Sasse M.E., and Ransohoff R.M. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Protoc 1 (2006) 1947-1951
12. Casadesus G., Webber K.M., Atwood C.S., Pappolla M.A., Perry G., Bowen R.L., and Smith M.A. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 1762 (2006) 447-452
13. Catlow B.J., Rowe A.R., Clearwater C.R., Mamcarz M., Arendash G.W., and Sanchez-Ramos J. Effects of environmental enrichment and physical activity on neurogenesis in transgenic PS1/APP mice. Brain Res 1256 (2009) 173-179
14. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., and Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408 (2000) 975-979
15. Costa D.A., Cracchiolo J.R., Bachstetter A.D., Hughes T.F., Bales K.R., Paul S.M., Mervis R.F., Arendash G.W., and Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging 28 (2007) 831-844
16. Cracchiolo J.R., Mori T., Nazian S.J., Tan J., Potter H., and Arendash G.W. Enhanced cognitive activity-over and above social or physical activity-is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 88 (2007) 277-294
17. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27 (1990) 457-464
18. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., and Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16 (1995) 285-298 discussion: 298-304
19. Ethell D.W., Shippy D., Cao C., Cracchiolo J.R., Runfeldt M., Blake B., and Arendash G.W. Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiol Dis 23 (2006) 351-361
20. Furuya T., Tanaka R., Urabe T., Hayakawa J., Migita M., Shimada T., Mizuno Y., and Mochizuki H. Establishment of modified chimeric mice using GFP bone marrow as a model for neurological disorders. Neuroreport 14 (2003) 629-631
21. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., and Murphy S.P. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 64 (2005) 763-769
22. Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 5 (1998) 221-225
23. Hasselblatt M., Jeibmann A., Riesmeier B., Maintz D., and Schabitz W.R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol 113 (2007) 45-51
24. Hickman S.E., Allison E.K., and El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28 (2008) 8354-8360
25. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., and Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96 (1999) 3228-3233
26. Imai Y., and Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 40 (2002) 164-174
27. Ishizuka K., Kimura T., Igata-yi R., Katsuragi S., Takamatsu J., and Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51 (1997) 135-138
28. Janelsins M.C., Mastrangelo M.A., Oddo S., La F.F.M., Federoff H.J., and Bowers W.J. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2 (2005) 23
29. Jensen M.T., Mottin M.D., Cracchiolo J.R., Leighty R.E., and Arendash G.W. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 130 (2005) 667-684
30. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., and Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26 (2006) 402-413
31. Kuethe F., Figulla H.R., Voth M., Richartz B.M., Opfermann T., Sayer H.G., Krack A., Fritzenwanger M., Hoffken K., Gottschild D., and Werner G.S. Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction. Dtsch Med Wochenschr 129 (2004) 424-428
32. Kuhn H.G., Cooper-Kuhn C.M., Boekhoorn K., and Lucassen P.J. Changes in neurogenesis in dementia and Alzheimer mouse models: are they functionally relevant?. Eur Arch Psychiatry Clin Neurosci 257 (2007) 281-289
33. Li S., Reinprecht I., Fahnestock M., and Racine R.J. Activity-dependent changes in synaptophysin immunoreactivity in hippocampus, piriform cortex, and entorhinal cortex of the rat. Neuroscience 115 (2002) 1221-1229
34. Lombardo J.A., Stern E.A., McLellan M.E., Kajdasz S.T., Hickey G.A., Bacskai B.J., and Hyman B.T. Amyloid-{beta} antibody treatment leads to rapid normalization of plaque-induced neuritic alterations 23 (2003) 10879-10883
35. Malm T.M., Koistinaho M., Parepalo M., Vatanen T., Ooka A., Karlsson S., and Koistinaho J. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18 (2005) 134-142
36. Meda L., Bernasconi S., Bonaiuto C., Sozzani S., Zhou D., Otvos Jr. L., Mantovani A., Rossi F., and Cassatella M.A. Beta-amyloid (25-35) peptide and IFN-gamma synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J Immunol 157 (1996) 1213-1218
37. Meuer K., Pitzer C., Teismann P., Krüger C., Göricke B., Laage R., Lingor P., Peters K., Schlachetzki J.C.M., Kobayashi K., Dietz G.P.H., Weber D., Ferger B., Schäbitz W.R., Bach A., Chulz J.B., Bähr M., Schneider A., and Weishaupt J.H. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem 97 (2006) 675-686
38. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., and McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20 (2000) 4050-4058
39. Nienaber C.A., Petzsch M., Kleine H.D., Eckard H., Freund M., and Ince H. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) S73-S77
40. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., and La F.F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 (2003) 409-421
41. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates (2001), Academic Press, San Diego, CA
42. Ray S., Britschgi M., Herbert C.T., Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., Kaye J.A., Leszek J., Miller B.L., Minthon L., Quinn J.F., Rabinovici G.D., Robinson W.H., Sabbagh M.N., So Y.T., Sparks D.L., Tabaton M., Tinklenberg J., Yesavage J.A., Tibshirani R., and Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13 (2007) 1359-1362
43. Ripa R.S., Jorgensen E., Wang Y., Thune J.J., Nilsson J.C., Sondergaard L., Johnsen H.E., Kober L., Grande P., and Kastrup J. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
44. Sanchez-Ramos J., Song S., Cao C., and Arendash G. The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review. BMC Neurosci 9 Suppl 2 (2008) S3
45. Sava V., Velasquez A., Song S., and Sanchez-Ramos J. Adult hippocampal neural stem/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin-A. Toxicol Sci 98 (2007) 187-197
46. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., Sommer C., and Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34 (2003) 745-751
47. Schabitz W.R., and Schneider A. Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials. Stroke 37 (2006) 1654 author reply: 1655
48. Scheff S.W., and Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24 (2003) 1029-1046
49. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., and Schabitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115 (2005) 2083-2098
50. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., and Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410 (2001) 372-376
51. Shors T.J., Townsend D.A., Zhao M., Kozorovitskiy Y., and Gould E. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12 (2002) 578-584
52. Shyu W.C., Lin S.Z., Lee C.C., Liu D.D., and Li H. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 174 (2006) 927-933
53. Simard A.R., Soulet D., Gowing G., Julien J.P., and Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006) 489-502
54. Six I., Gasan G., Mura E., and Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 458 (2003) 327-328
55. Solaroglu I., Jadhav V., and Zhang J.H. Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci 12 (2007) 712-724
56. Solaroglu I., Tsubokawa T., Cahill J., and Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 143 (2006) 965-974
57. Stern E.A., Bacskai B.J., Hickey G.A., Attenello F.J., Lombardo J.A., and Hyman B.T. Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. J Neurosci 24 (2004) 4535-4540
58. Suzuki K., Nagashima K., Arai M., Uno Y., Misao Y., Takemura G., Nishigaki K., Minatoguchi S., Watanabe S., Tei C., and Fujiwara H. Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease. Circ J 70 (2006) 430-437
59. Takano H., Ohtsuka M., Akazawa H., Toko H., Harada M., Hasegawa H., Nagai T., and Komuro I. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 9 (2003) 1121-1127
60. Terry R.D. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 55 (1996) 1023-1025
61. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30 (1991) 572-580
62. Tsai K.J., Tsai Y.C., and Shen C.K. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med 204 (2007) 1273-1280
63. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
64. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
65. Zhang Z., and Ma Q.J. Prophylactic and therapeutic vaccines against Alzheimer's disease. Sheng Wu Gong Cheng Xue Bao 19 (2003) 641-645
66. Zhao L.R., Navalitloha Y., Singhal S., Mehta J., Piao C.S., Guo W.P., Kessler J.A., and Groothuis D.R. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol 204 (2007) 569-573